ILIAS Biologics
Developing engineered exosomes to deliver therapeutic proteins for treating life-threatening diseases. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
$82—124m (Dealroom.co estimates Sep 2020.)
Daejeon South Korea (HQ)
Authorizing premium user...